Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2009

Sep 1, 2009

30339_dirs_2009-09-01_94375dce-a570-4384-ba34-de0bfdf46374.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-08-31

Reporting Person: ELLERS STEVEN A (COO & President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-08-31 Common Stock M 10000 $13.0157 Acquired 125210.302 Direct
2009-08-31 Common Stock S 10000 $39.886 Disposed 115210.302 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-08-31 Stock Option (Right to Buy) $13.0157 M 10000 Disposed 2005-03-25 Common Stock (10000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3415.0261 Indirect
Common Stock 33121.4471 Indirect